[Retracted] Higher Chronic Endometritis Incidences within Infertile Polycystic Ovary Syndrome Clinical Cases

Table 3

Clinical characteristics of endometrial hyperemia and nonendometrial hyperemia cohorts.

	Hyperemia cohort (n = 354)	Nonhyperemia cohort (n = 2982)	value	95% CI
Age, years	31.19 ± 3.52	31.89 ± 3.52	0.101	0.925–1.007
Infertility duration, years	3.80 ± 2.37	3.75 ± 2.52	0.792	0.950–1.070
BMI (kg/m^2)	24.77 ± 3.39	23.64 ± 3.46	<0.001	1.064–1.164
Infertility
Primary infertility %	192 (54.24%)	1498 (50.23%)	0.855	0.775–1.235
Secondary infertility %	162 (45.76%)	1484 (49.77%)
bFSH (UI/L)	6.53 ± 1.77	6.71 ± 1.87	0.975	0.914–1.097
bLH (UI/L)	6.91 ± 4.10	5.57 ± 3.01	<0.001	1.058–1.149
bE2 (pg/ml)	34.33 ± 13.78	34.77 ± 13.94	0.774	0.998–1.009
bP (ng/ml)	0.50 ± 0.29	0.52 ± 0.26	0.144	0.380–1.152
bT(ng/ml)	0.32 ± 0.16	0.26 ± 0.14	<0.001	4.917–19.946
PRL (ng/ml)	16.74 ± 6.59	17.30 ± 6.25	0.823	0.976–1.019
AMH (ng/ml)	7.21 ± 4.83	4.92 ± 2.78	<0.001	1.028–1.095
CA125 (U/ml)	20.89 ± 8.85	22.99 ± 7.17	0.470	0.997–1.007
CHOL(mmol/L)	4.83 ± 0.87	4.78 ± 0.86	0.880	0.559–1.647
LDL-C (mmol/L)	2.84 ± 0.78	2.85 ± 0.95	0.946	0.558–1.724
TG (mmol/L)	1.22 ± 0.92	1.08 ± 0.86	0.675	0.731–1.225